July 17, 2007 – Premier recently announced that it has extended its agreement with MEDRAD Inc. to provide vascular injection systems and related disposables used in Computed Tomography (CT), Magnetic Resonance (MR) and Cardiovascular (CV) imaging for two additional years.
The contract includes MEDRAD's complete portfolio of injection systems, including the Stellant CT Injection System with DualFlow, the MEDRAD Avanta fluid management injection system for improved cardiovascular imaging and Spectris Solaris EP MR injection system for advanced MR studies. MEDRAD introduced the first vascular injection systems used in CT, MR and cardiovascular imaging procedures and reportedly has 98 percent customer satisfaction ratings in North America for product reliability.
For more information: www.medrad.com
October 28, 2026 
